期刊文献+

神经元凋亡在帕金森病中的作用 被引量:5

Role of Neuronal Apoptosis in Parkinson Disease
下载PDF
导出
摘要 帕金森病(PD)以静止性震颤、肌肉僵硬、运动迟缓和姿势不稳为临床特征,是一种中老年人常见的中枢系统退行性疾病,主要病理变化为黑质部位的多巴胺能神经元变性导致黑质纹状体多巴胺含量减少以及路易小体形成。PD的病因和发病机制至今尚未明确,凋亡在PD发病机制中占有十分重要的地位,现就神经元凋亡在PD中的作用予以综述。 The main clinical features of Parkinson disease(PD)include static tremor,rigidity,bradykinesia and postural instability.It is a common neurodegenerative disease in central nervous system of the middle and old aged people.The primary pathology of PD is degeneration of dopaminergic neurons in the substantia nigra,resulting in loss of the nigrostriatal pathway and a reduction of dopamine contents in the striatum and the Lewy body formation.The etiology and pathogenesis of PD are still indefinite.Apoptosis is intimately linked to other components of neurodegenerative process.Here is to make a review on the possible role of neuron apoptosis in PD.
出处 《医学综述》 2012年第7期1004-1006,共3页 Medical Recapitulate
关键词 帕金森病 凋亡 病因学 Parkinson disease Apoptosis Etiology
  • 相关文献

参考文献28

  • 1Dawson TM,Dawson VL.Molecular pathways of neurodegenerationin parkinson's disease[J].Science,2003,302(5646):819-822.
  • 2Dawson TM,Dawson VL.Rare genetic mutations shed light on thepathogenesis of Parkinson disease[J].J Clin Invest,2003,111(2):145-151.
  • 3Iannolo G,Conticello C,Memeo L,et al.Apoptosis in normal andcancer stem cells[J].Crit Rev Oncol Hematol,2008,66(1):42-51.
  • 4Radad K,Gille G,Rausch WD.Dopaminergic neurons are prefer-entially sensitive to long-term rotenone toxicity in primary cell cul-ture[J].Toxicol In Vitro,2008,22(1):68-74.
  • 5Wang ZB,Liu YQ,Cui YF.Pathways to caspase activation[J].Cell Biol Int,2005,29(7):489-496.
  • 6Andoh T,Chock PB,Murphy DL,et al.Role of the redox proteinthioredoxin in cytoprotective mechanism evoked by(-)-deprenyl[J].Mol Pharmacol,2005,68(5):1408-1414.
  • 7Pinti M,Troiano L,Nasi M,et al.Genetic polymorphisms of Fas(CD95)and FasL(CD178)in human longevity:studies on centenar-ians[J].Cell Death Differ,2002,9(4):431-438.
  • 8Ferrer R,Blanco B,Cutilla S,et al.Fas and Fas-L,expression inHuntington's disease and Parkinson's disease[J].Neuropathol Ap-pl Neurobiol,2000,26(5):424-433.
  • 9Mogi M,Harada M,Kondo T,et al.The soluble form of Fas mole-cule is elevated in parkinsonian brain tissues[J].Neurosci Lett,1996,220(3):195-198.
  • 10Esther BB,Bonni A.Cell cycle regulation of neuronal apoptosis indevelopment and disease[J].Prog Neurobiol,2004,72(1):1-25.

二级参考文献32

  • 1Nagastu T.Isoquinoline neurotoxins in the brain and Parkinson's disease [J].Neurosci Res,1997,29:99~111.
  • 2Benveniste EN,Kwon J,Chung WJ,et al.Differential modulation of astrocyte cytokine gene expression by TGF beta [J].J Immunol,1994,153:5210~5221.
  • 3Logan A.CNS growth factors [J].Br J Hosp Med,1990,43:428~437.
  • 4Fonck C, et al. [J]. Brain Res, 2003, 975(1-2) :214-221.
  • 5Fiskum G, et al. [J]. Ann NY Acad Sci, 2003,991:111-119.
  • 6Bachurin SO, et al. [ J]. Ann NY Acad Sci,2003, 993:334-344.
  • 7Park TH, et al. [ J]. Neurosci Res, 2003, 46(3) :349-358.
  • 8Sheng G, et al. [J]. Planta Med, 2002, 68( 11 ) : 966-970.
  • 9Mandavilli BS. [J]. Brain Res, 2000, 885(1) :45-52.
  • 10Iwaasa M, et al. [J]. J Neurochem, 2002, 82(1) : 30-37.

共引文献31

同被引文献72

  • 1朱亚平,周雨,刘静,王乐,凌晖.凋亡相关蛋白死亡受体5、细胞内Fas相关死亡域样白介素1-β转换酶抑制蛋白在胃组织中的表达及临床意义[J].中国老年学杂志,2014,34(1):42-43. 被引量:3
  • 2刘雨清,张伟栋,李媛媛.一种新的帕金森病动物模型[J].中国实验动物学报,2007,15(2):159-160. 被引量:8
  • 3Hassouna I, Wickert H, Zimmermann M, et al. Increase in bax ex- pression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine(MPTP) treatment of mice [ J ]. Neurosci Lett, 1996, 2004: 85-88.
  • 4XuBB, Liu CQ, Gao X, et al. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model [ J ]. J Asian Nat Prod Res, 2005, 7:215 -224.
  • 5Brown KD, Clandio E, Siebenlist U. The roles of the classical and al- ternative nuclear factor-kb pathways : potential implications for auto- immunity and rheumatoid arthritis [ J ]. Arthritis Res Ther, 2008, 10:212 - 225.
  • 6Arumugam TV, Woodruff TM, Lathia JD, et al. Neuroprotection in stroke by complement inhibition and immunoglobnlin therapy [ J ] . Neuroscience, 2009, 158 : 1074 - 1089.
  • 7Karin M. Nuclear factor-kappaB in cancer development and progres- sion [ J ]. 2006, 441:431 - 436.
  • 8Toruner M, Femandez-Zapici M, Sha JJ, et al. Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprote- gerin, BCL-2, and IAP-1 [ J]. J Biol Chem, 2006, 28 : 8686 - 8689.
  • 9Bove J, Pefier C. Neurotoxin-based models of Parkinson's disease [J]. Neuroscience, 2012, 211 : 51 -76.
  • 10Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's dis- ease[J]. Brain Res Mol Brain Res, 2005, 134:57 -66.

引证文献5

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部